KineMed
KineMed Collaborates With Pfizer on Proteomics Biomarkers
Building on the companies' existing relationship, the deal licenses KineMed's proteomics platform to the pharmaceuticals giant for CDx development.
KineMed, Pronutria Ink R&D Collaboration
The partners will use KineMed's proteomics platform to evaluate the effect of biologics developed by Pronutria for metabolic and other diseases.
In Brief This Week: Agilent Technologies; Diagnocure; KineMed, Pfizer; PositiveID; SomaLogic
NEW YORK (GenomeWeb) – Agilent Technologies said this week that it has mad an adjustment to its second quarter 2014 GAAP net income.
NEW YORK (GenomeWeb News) – KineMed this week announced the renewal of its non-exclusive research collaboration with Pfizer into metabolic disease, and type 2 diabetes in particular.
NEW YORK (GenomeWeb News) – KineMed said this week that it has extended its collaboration with the CHDI Foundation on research into biomarkers for Huntington's disease.
May 23, 2014
Aug 23, 2013
Mar 27, 2013
KineMed, Pfizer Renew Research Collaboration
Feb 21, 2013
Jun 18, 2012
KineMed, GSK Partner on Biomarker Discovery Deal
Mar 11, 2011